Necrotic, rather than apoptotic, cell death caused by cytochrome P450–activated ifosfamide

被引:0
|
作者
Peter Karle
Matthias Renner
Brian Salmons
Walter H Günzburg
机构
[1] Institute of Virology,
[2] University of Veterinary Sciences,undefined
[3] Vienna,undefined
[4] Bavarian Nordic GmbH,undefined
[5] Austrian Nordic AG,undefined
来源
Cancer Gene Therapy | 2001年 / 8卷
关键词
Cytochrome P450 2B1; ifosfamide; necrosis; apoptosis; bystander effect; suicide gene;
D O I
暂无
中图分类号
学科分类号
摘要
Feline kidney cells were transfected with a vector overexpressing cytochrome P450 2B1 (CYP2B1). Transfected cells acquired a new specific biochemical activity, which could be demonstrated by a rapid CYP2B1 detection assay and showed selective sensitivity to the antitumorigenic prodrug ifosfamide (IFO). Further, the cell-killing effect was also mediated on nonmodified cells like feline kidney cells, mouse lymphoma, and human pancreatic cells in the vicinity of the CYP2B1-expressing cells due to the diffusible nature of the activated IFO metabolites. One of these, phosphoramide mustard, causes interstrand DNA cross-linking and it has been thought that the inability to repair this damage results in apoptosis. Surprisingly, our results clearly demonstrate a necrotic mechanism of IFO-induced cell death. This may have important implications for the activation of the immune system during CYP2B1/IFO suicide gene therapy of cancer. Cancer Gene Therapy (2001) 8, 220–230
引用
收藏
页码:220 / 230
页数:10
相关论文
共 50 条
  • [1] Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide
    Karle, P
    Renner, M
    Salmons, B
    Günzburg, WH
    CANCER GENE THERAPY, 2001, 8 (03) : 220 - 230
  • [2] Arachidonic acid induces neuronal death through lipoxygenase and cytochrome P450 rather than cyclooxygenase
    Kwon, KJ
    Jung, YS
    Lee, SH
    Moon, CH
    Baik, EJ
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 81 (01) : 73 - 84
  • [3] Apoptotic tumor cell death is more immunogenic than necrotic tumor cell death
    Gamrekelashvili, J.
    Krueger, C.
    Manns, M. P.
    von Wasielewski, R.
    Korangy, F.
    Greten, T. F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (03) : 419 - 419
  • [4] Cytochrome P450 in renal cell cancer
    Mitchell, RT
    McFadyen, MCE
    Cheung, YL
    Melvin, WT
    Murray, GI
    JOURNAL OF PATHOLOGY, 1998, 184 : 30A - 30A
  • [5] Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes
    Liu, Yong
    Zhang, Jiang-Wei
    Li, Wei
    Ma, Hong
    Sun, Jie
    Deng, Mai-Cun
    Yang, Ling
    TOXICOLOGICAL SCIENCES, 2006, 91 (02) : 356 - 364
  • [6] Rifabutin autoinduction is caused by involvement of cytochrome P450 and cholinesterase
    Zhaoxu, L.
    Jingcheng, T.
    Jinnan, Z.
    PHARMAZIE, 2008, 63 (02): : 156 - 159
  • [7] Ligand activated transcription factors in control of cytochrome P450
    Gustafsson, JA
    FASEB JOURNAL, 1997, 11 (09): : A769 - A769
  • [8] Effect of cytochrome P450 inducers and inhibitors on viability and activated cell death in a murine T-lymphocyte hybridoma.
    Pernecky, SJ
    Wanji, BN
    Bhaskara, V
    FASEB JOURNAL, 1999, 13 (07): : A1345 - A1345
  • [9] Pharmacokinetics of ifosfamide and cytochrome P450 3A in a phase II trial of doxorubicin and ifosfamide in sarcoma patients.
    Chung, R
    Thomas, DG
    Wagner, T
    Griffith, K
    Taylor, J
    Worden, F
    Schuetze, S
    Zalupski, MM
    Baker, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 143S - 143S
  • [10] N-nitrosodimethylamine-mediated cytotoxicity in cells transfected with cytochrome P450 2E1:: Evidence for apoptotic cell death
    Lin, HI
    Hollenberg, PF
    FASEB JOURNAL, 1997, 11 (09): : A827 - A827